Trials
(May 2020)
Correction to: Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden
- Erik Lundström,
- Eva Isaksson,
- Per Näsman,
- Per Wester,
- Björn Mårtensson,
- Bo Norrving,
- Håkan Wallén,
- Jörgen Borg,
- Martin Dennis,
- Gillian Mead,
- Graeme J. Hankey,
- Maree L. Hackett,
- Katharina S. Sunnerhagen,
- For the EFFECTS Trial Collaboration
Affiliations
- Erik Lundström
- Department of Neuroscience, Neurology, Uppsala University, Akademiska, Sjukhuset
- Eva Isaksson
- Department of Clinical Neuroscience, Neurology, Karolinska Institutet
- Per Näsman
- Centre for Safety Research, KTH Royal Institute of Technology
- Per Wester
- Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet
- Björn Mårtensson
- Department of Clinical Neuroscience, Karolinska Institutet
- Bo Norrving
- Department of Clinical Sciences, Lund, Neurology, Skåne University Hospital, Lund University
- Håkan Wallén
- Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd Hospital, Karolinska Institutet
- Jörgen Borg
- Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet
- Martin Dennis
- Royal Infirmary, University of Edinburgh
- Gillian Mead
- Royal Infirmary, University of Edinburgh
- Graeme J. Hankey
- Medical School, The University of Western Australia
- Maree L. Hackett
- The George Institute for Global Health, Faculty of Medicine, University of New South Wales Sydney
- Katharina S. Sunnerhagen
- Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg
- For the EFFECTS Trial Collaboration
- DOI
-
https://doi.org/10.1186/s13063-020-04327-w
- Journal volume & issue
-
Vol. 21,
no. 1
pp.
1
– 1
Abstract
Read online
Following publication of the original article [1], we were notified that one of the corresponding author’s affiliations was omitted.
WeChat QR code
